logo-loader
Proactive Group

Opsepio Therapeutics looks to raise $30mln for its Phase 1 ready cancer treatment

Opsepio Therapeutics Inc CEO Michael Stocum talks to Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.

The company has identified a molecule to treat all kinds of cancers, and is looking to develop it into Phase 1 early summer. Stocum says the company is looking to raise $30mln to take the company through clinical studies.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

2 days, 4 hours ago

2 min read